RSRoberto Sierra

Roberto Sierra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Roberto Sierra has a total of 203 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Limb salvage in a Ukrainian soldier with Klebsiella pneumoniae osteomyelitis: phage-antibiotic therapy despite anti-phage antibodies

    by Karlis Racenis, Renate Apse, Lise Berentsen, Sandis Maurins, Dace Eglite, Nikita Zrelovs, Krystyna Dąbrowska, Zuzanna Kazmierczak, Roberto Sierra, Diego Andrey, et al.

    Chronic osteomyelitis caused by antibiotic-resistant bacteria represents a major therapeutic challenge, particularly in patients with war-related traumatic injuries, where prolonged hospitalization and extensive tissue damage increase the emergence of resistant pathogens. Treatment of Klebsiella pneumoniae poses distinctive challenges in this context, as phage-host interactions are predominantly determined by the pathogen's hypervariable polysaccharide capsule, which restricts phage activity to strains with compatible capsular receptor structures and necessitates highly individualized phage selection. However, clinical evidence remains limited, and detailed description of immunological response to treatment is still scarce. We report a case of chronic femur osteomyelitis caused by multidrug-resistant (MDR) K. pneumoniae in a Ukrainian war-trauma patient, successfully treated with a multimodal informed selected bacteriophage regimen combining systemic intravenous, local intraoperative, and continuous intramedullary administration alongside targeted antibiotic therapy. Serial serological and cytokine profiling were performed before, during, and after the treatment to characterize the immunological response. Immunological profiling showed consistent antigen recognition for both phages used. Elevated baseline serum IgA titres specific to one phage demonstrated prior mucosal exposure to this or a structurally similar phage. Notably, serum-mediated phage neutralization exceeded 99% by day 11 of treatment yet did not impair therapeutic effectiveness. This case demonstrates that multimodal phage delivery combined with antibiotic treatment can lead to infection resolution in MDR osteomyelitis despite a robust anti-phage immune response.

  • Open Access

    Emergence and dissemination of an IncC plasmid co-harbouring bla KPC-2, bla NDM-1 and bla VIM-24 carbapenemase genes across multiple Gram-negative species in Colombia

    by Roberto Sierra, Betsy Castro, Elsa De La Cadena, Laura J Rojas, Juan Carlos García-Betancur, Mélanie Roch, Steven M Marshall, Nalleth Bolaño-Ardila, Susan D Rudin, Janneth J Escobar-Arcos, et al.

    Objectives: Carbapenem-resistant Gram-negative bacilli (CRGNB) pose a public health threat, increasingly driven by plasmid-mediated dissemination of carbapenemase genes. As part of a Colombian genomic monitoring programme, we aimed to characterize CRGNB co-harbouring multiple carbapenemase genes and determine their genetic context. Methods: We screened 832 carbapenem-resistant isolates collected during 2011–2023 using carbapenemase-targeted qPCR. Ten isolates co-harbouring blaKPC, blaNDM and blaVIM underwent antimicrobial susceptibility testing, long-read whole-genome sequencing, comparative genomics and conjugation assays. Results: Nine Enterobacterales isolates and one Aeromonas caviae isolate from unrelated patients in geographically distant Colombian hospitals carried closely related IncC plasmids ranging from 160 to 317 kb. These plasmids co-harboured blaKPC-2, blaNDM-1 and blaVIM-24 within three conserved multidrug resistance regions, including a Tn21-associated region carrying blaNDM-1 and blaVIM-24 and a Tn6454-associated blaKPC-2 platform, alongside class 1 integrons, insertion sequences and multiple additional antimicrobial resistance determinants. The ten isolates were resistant to multiple β-lactam/β-lactamase inhibitor combinations, and five were cefiderocol resistant. Aztreonam/avibactam remained active against all isolates; colistin resistance was confined to intrinsically resistant Providencia rettgeri and Serratia sarumanii. Conjugation assays demonstrated plasmid transfer to Escherichia coli J53, and sequencing confirmed transfer of a 179 kb IncC plasmid with functional conjugation machinery. Comparative genomic analysis showed a highly conserved IncC plasmid backbone across multiple species, supporting broad dissemination of this resistance platform. Conclusions: This first report of a single plasmid co-harbouring three carbapenemase genes. This finding highlights a concerning mechanism for interspecies dissemination of MDR Gram-negative pathogens and underscores the importance of long-read genomic surveillance focused on high-risk plasmids.

  • Open Access

    Reduced chlorhexidine susceptibility in multidrug-resistant Klebsiella pneumoniae; genomic and functional analysis of invasive isolates

    by Mélanie Roch, Gaël Panis, Roberto Sierra, Ana C. Gales, Diego O. Andrey

  • Open Access

    Synergistic activity of a KL51-depolymerase and a Sugarlandvirus bacteriophage against ST16 Klebsiella pneumoniae

    by Mélanie Roch, Roberto Sierra, Gaël Panis, Willames B. Martins, Diego Andrey

    The rising prevalence of multidrug-resistant Klebsiella pneumoniae strains, particularly the emerging high-risk ST16 lineage, highlights the urgent need for alternative therapeutic strategies. A major barrier to effective bacteriophage (phage) therapy against K. pneumoniae is its polysaccharide capsule, which hinders phage access to surface receptors. In this study, we identified and characterized an anti-KL51 capsule depolymerase derived from the anti-ST16 phage PWKp9B. The recombinant DpoK51-9B enzyme was expressed in Escherichia coli , purified, and shown to degrade the KL51 capsule using Percoll density gradient, halo formation on double-layered-agar, and FITC-dextran exclusion assays. The depolymerase exhibited strong activity at nanomolar concentrations, retained function up to 50°C, and was active only against KL51-positive strains, including ST16 and ST231 isolates, but not against strains with other capsule types. Importantly, the depolymerase enabled the lytic activity of the Sugarlandvirus phage GPH82, normally inactive against encapsulated ST16, demonstrating potent phage-depolymerase synergy. These findings highlight the potential of recombinant depolymerases to expand phage host range by unmasking the phage receptors on the surface of the bacteria and therefore enhance the efficacy of phages against encapsulated bacteria. IMPORTANCE: Bacteriophage therapy and phage-derived therapeutics are attracting increasing attention as promising alternatives or adjuvants to antibiotics in the treatment of multidrug-resistant bacterial infections. Among phage-encoded enzymes, depolymerases are of particular interest due to their ability to degrade the bacterial polysaccharide capsule that prevents phage adsorption. Our results highlight the utility of combining recombinant depolymerases with phages to broaden their host range and enhance their activity against encapsulated, drug-resistant pathogens.


  • Open Access

    Phage therapy for KPC-producing Klebsiella pneumoniae decolonization in high-risk patients: The KIDNAP Study Protocol – A prospective feasibility and proof of concept study in the Brazilian context

    by Iris Najjar, Larissa Simão Gandolpho, Jôiciglecia Pereira dos Santos, Camila de Paula Siqueira, Ikechukwu B. Moses, Ághata Cardoso da Silva Ribeiro, Mélanie Roch, Roberto Sierra, Diego O. Andrey, Celso Arrais-Rodrigues, et al.


  • Open Access

    A two-component system signaling hub controls enterococcal membrane remodeling in response to daptomycin

    by Cristina Colomer-Winter, Zeus J. Nair, Jerome Y. J. Chua, Soukayna Jabli, Mélanie Roch, Amaury Cazenave-Gassiot, Roberto Sierra, Diego O. Andrey, Shu-Sin Chng, Kimberly A. Kline

    Daptomycin is a last resort antibiotic used to treat vancomycin-resistant enterococcal infections, but daptomycin resistance (DAP R ) arises quickly during treatment. Resistance is due to sequential acquisition of point mutations in the two-component system LiaFSR and in cardiolipin synthases and is associated with alteration of phospholipid and glycolipid membrane composition. The molecular mechanisms underlying these lipid changes are currently unknown. Similarly, it is unclear why mutations in liaFSR occur prior to mutations in cls . We discovered that Enterococcus faecalis remodels membrane composition as a phenotypic response to daptomycin that parallels the membrane composition of DAP R strains. The enrichment in glycolipids that follows antibiotic exposure is due to LtaS1, the main LTA synthase of E. faecalis . Moreover, LtaS1 activity is governed by a network of two-component systems formed by LiaFSR, SapRS, and BsrRS that couple antibiotic sensing with membrane lipid remodeling. Together, our results provide a unifying mechanism that drives phenotypic membrane fortification in a Gram-positive pathogen which simultaneously predisposes the cell to acquire genetic high-level daptomycin resistance. Significance Statement: Daptomycin is the preferred alternative to treat vancomycin-resistant Enterococcus infections. However, the efficacy of daptomycin is limited by the acquisition of daptomycin resistance. Alterations in lipid membrane composition represent a conserved strategy to fortify the Gram-positive membrane. We discovered that E. faecalis phenotypically remodels membrane composition in response to daptomycin and that the enrichment in glycolipids is dependent on LTA synthesis. We expand our limited knowledge of enterococcal LTA synthases, confirming LtaS1 as the main LTA synthase and placing LTA biogenesis under control of a network of antibiotic-responsive two-component systems. Our work provides a molecular explanation for the sequential evolution of daptomycin resistance and may support the use of existing LtaS inhibitors to prevent acquisition of daptomycin resistance.


  • Open Access

    Horizontal transmission of a multidrug-resistant IncM1 plasmid harbouring blaOXA-48 and blaCTX-M-14b among patient microbiotas

    by Roberto Sierra, Mélanie Roch, Julien Prados, Aude Nguyen, Abdessalam Cherkaoui, Gesuele Renzi, Jacques Schrenzel, Stephan Harbarth, Nicolas Vuilleumier, Diego O Andrey


  • Open Access

    Genomic characterization of plasmids harboring bla NDM-1, bla NDM-5, and bla NDM-7 carbapenemase alleles in clinical Klebsiella pneumoniae in Pakistan

    by Muhammad Usman Qamar, Roberto Sierra, Kokab Jabeen, Muhammad Rizwan, Ayesha Rashid, Yumna Fatima Dar, Diego O. Andrey

    Klebsiella pneumoniae is notorious for causing healthcare-associated infections, which become more complicated by the acquisition of bla NDM genes via mobile genetic elements. Although Pakistan is a well-established hot spot of bla NDM -positive K. pneumoniae , detailed molecular descriptions of bla NDM -carrying plasmids are scarce. Seven K. pneumoniae isolates harboring bla NDM were recovered from clinical sample sources during a 6 month period and tested for antimicrobial susceptibility. A long-read approach was used for whole-genome sequencing to obtain circularized plasmids and chromosomes for typing, annotation, and comparative analysis. The isolates were susceptible to colistin and tigecycline only among the tested antibiotics. We identified five sequence types (STs): ST11, ST16, ST716, ST464, and ST2856. Notably, three strains possessed the hypervirulent capsule KL2, while five were classified as O locus type O2a. Evidence of genetic diversity was further highlighted by the presence of four IncC plasmids harboring bla NDM-1 , two IncX3 plasmids harboring bla NDM-5 , and a single hybrid IncFIB/IncHI1B plasmid harboring bla NDM-7 . These plasmids also carried additional antimicrobial resistance (AMR) genes conferring resistance to aminoglycosides, cephalosporins, and fluoroquinolones. We identified the plasmidome of the K. pneumoniae isolates and characterized the New Delhi metallo-beta-lactamase (NDM)-carrying plasmids. Genetic analysis confirmed the presence of bla NDM-1 and bla NDM-5 on broad host range plasmids and bla NDM- 7 in a previously unreported hybrid plasmid backbone. We emphasized the critical role of plasmids in spreading bla NDM in the clinical setting in Pakistan. Hence, we stressed the urgent need for enhanced surveillance, not least in low-middle income countries, infection control measures, and adherence to the “Access,” “Watch,” and “Reserve” guidelines in antibiotics use. IMPORTANCE: Infections caused by NDM-producing Klebsiella pneumoniae are a significant challenge to treat and represent a crucial health burden in low- and middle-income countries (LMICs). Most of the bla NDM are located on plasmids that promote horizontal gene transfer. However, there is a lack of comprehensive information on the genetic context of the NDM-carrying plasmids in Pakistan. This study presents a detailed analysis of seven NDM-plasmids in clinical K. pneumoniae isolates, shedding light on their high-risk sequence types and multiple resistance determinants. We also describe the plasmid-bearing NDM alleles ( bla NDM-1 , bla NDM-5 , and bla NDM-7 ). Notably, we are the first to report bla NDM-7 on the hybrid IncFIB/IncHI1B backbone in Pakistan, a plasmid that has rarely been reported previously globally. Understanding the plasmid genomic landscape is paramount to comprehensively understanding the AMR scenario in this LMIC.


  • Open Access

    Genomic characterization of plasmids harboring bla NDM-1,-5,-7 carbapenemase alleles in clinical Klebsiella pneumoniae in Pakistan

    by Muhammad Usman Qamar, Roberto Sierra, Kokab Jabeen, Muhammad Rizwan, Ayesha Rashid, Yumna Fatima Dar, Diego O. Andrey

    Klebsiella pneumoniae is notorious for causing healthcare-associated infections, which become more complicated by the acquisition of bla NDM genes via mobile genetic elements. Although Pakistan is a well-established hot spot of bla NDM -positive K. pneumoniae , detailed molecular descriptions of bla NDM -carrying plasmids are scarce. Seven K. pneumoniae isolates harboring bla NDM were recovered from clinical sample sources during a six-month period and tested for antimicrobial susceptibility. A long-read approach was used for whole genome sequencing to obtain circularized plasmids and chromosomes for typing, annotation, and comparative analysis. The isolates were susceptible to colistin and tigecycline only among the tested antibiotics. We identified five STs: ST11, ST16, ST716, ST464, and ST2856. Notably, three strains possessed the hypervirulent capsule KL2, while five were classified as O locus type O2a. Evidence of genetic diversity was further highlighted by the presence of four IncC plasmids harboring bla NDM-1 , two IncX3 plasmids harboring bla NDM-5 , and a single hybrid IncFIB/IncHI1B plasmid harboring bla NDM-7 . These plasmids also carried additional ARGs conferring resistance to aminoglycosides, cephalosporins, and fluoroquinolones. We identified the plasmidome of the K. pneumoniae isolates and characterized the NDM-carrying plasmids. Genetic analysis confirmed the presence of bla NDM-1 and bla NDM-5 on broad host range plasmids and bla NDM-7 in a previously unreported hybrid plasmid backbone. We emphasized the critical role of plasmids in spreading bla NDM in the clinical setting in Pakistan. Hence, we stressed the urgent need for enhanced surveillance, not least in LMICs, infection control measures, and adherence to the AWaRe guidelines in antibiotics use.


  • Open Access

    Contributions of Long-Read Sequencing for the Detection of Antimicrobial Resistance

    by Roberto Sierra, Mélanie Roch, Milo Moraz, Julien Prados, Nicolas Vuilleumier, Stéphane Emonet, Diego O. Andrey

    Background. In the context of increasing antimicrobial resistance (AMR), whole-genome sequencing (WGS) of bacteria is considered a highly accurate and comprehensive surveillance method for detecting and tracking the spread of resistant pathogens. Two primary sequencing technologies exist: short-read sequencing (50–300 base pairs) and long-read sequencing (thousands of base pairs). The former, based on Illumina sequencing platforms (ISPs), provides extensive coverage and high accuracy for detecting single nucleotide polymorphisms (SNPs) and small insertions/deletions, but is limited by its read length. The latter, based on platforms such as Oxford Nanopore Technologies (ONT), enables the assembly of genomes, particularly those with repetitive regions and structural variants, although its accuracy has historically been lower. Results. We performed a head-to-head comparison of these techniques to sequence the K. pneumoniae VS17 isolate, focusing on blaNDM resistance gene alleles in the context of a surveillance program. Discrepancies between the ISP (blaNDM-4 allele identified) and ONT (blaNDM-1 and blaNDM-5 alleles identified) were observed. Conjugation assays and Sanger sequencing, used as the gold standard, confirmed the validity of ONT results. This study demonstrates the importance of long-read or hybrid assemblies for accurate carbapenemase resistance gene identification and highlights the limitations of short reads in the context of gene duplications or multiple alleles. Conclusions. In this proof-of-concept study, we conclude that recent long-read sequencing technology may outperform standard short-read sequencing for the accurate identification of carbapenemase alleles. Such information is crucial given the rising prevalence of strains producing multiple carbapenemases, especially as WGS is increasingly used for epidemiological surveillance and infection control.